Robbins Headache Clinic Blog
“Erenumab Bests Topiramate in Head-to-Head Migraine Prevention Study” from MPR
Novartis announced positive results from a phase 4 study comparing treatment with erenumab (Aimovig), a calcitonin gene-related peptide (CGRP) receptor antagonist, to topiramate in patients with episodic and chronic migraine. The randomized, double-blind,...
“Pfizer’s Covid Vaccine: 11 Things You Need to Know” from The New York Times
As coronavirus cases surge in the United States and elsewhere, with little relief in sight, the world got good news on Monday. Pfizer and its partner, the German company, BioNTech, announced preliminary results that suggested their vaccine was more than 90 percent...
“Migraine and Weather: Tips to manage your Symptoms” from Nuvance Health
Many people who get migraines experience worsening symptoms during extreme weather changes, hot or humid summer weather, or changes in barometric pressure. Several studies attempting to find a scientific correlation between weather and migraines have yielded...
“Serve Up Some Extra Precautions at Your Thanksgiving Table This Year” from The New York Times
It’s been a year of sacrifice, social distancing and skyrocketing stress. Can we at least enjoy Thanksgiving? In terms of risk, the timing of the Thanksgiving holiday couldn’t be worse. The coronavirus is raging across the country, setting new daily infection records....
“Can You Paint Your Migraine?” from San Diego County News
“Can you draw me a picture of your headache?” may sound like an unusual question – but drawings of headache pain provide plastic surgeons with valuable information on which patients are more or less likely to benefit from surgery to alleviate migraine headaches....
“Peak Anxiety? Here are 10 Ways to Calm Down” from The New York Times
Can’t concentrate? Losing sleep? Binge-eating your feelings? In a year of unprecedented stress, the nation collectively appears to be heading toward peak anxiety this week. People are sharing stories of stress eating, clearing their calendars (who could sit through a...
“Fremanezumab Found to Reduce Number of Migraine Days in Patients with Chronic Migraine and Comorbid Depression” from Psychiatry Advisor
Treatment with fremanezumab, the fully humanized IgG2?a monoclonal antibody that selectively targets calcitonin gene-related peptide, significantly reduced the number of headache or migraine days experienced before therapy. These findings, from a pooled analysis of...
“Most Migraine Patients Lack Treatment” from MedPage Today
Fewer than one in three people with migraine took guideline-recommended prescription medication, data presented at the American Headache Society (AHS) annual scientific meeting showed. About 28% of survey respondents with mild to severe migraine-related...
“Respecting Children’s Pain” from The New York Times
In a new report on pediatric pain in the British medical journal The Lancet, a commission of experts, including scientists, doctors, psychologists, parents and patients, challenged those who take care of children to end what they described as the common...
“Do You Have the Heart for Marijuana?” from The New York Times
Do you have the heart to safely smoke pot? Maybe not, a growing body of medical reports suggests. Currently, increased smoking of marijuana in public, even in cities like New York where recreational use remains illegal (though no longer prosecuted), has reinforced a...